Stanford University School of Medicine Palo Alto, California, United States — Palo Alto, California

Stanford University School of Medicine Palo Alto, California, United States is a clinical research site located in Palo Alto, California, United States 94305.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford University School of Medicine Palo Alto, California, United States has participated in 1 clinical trials.

Therapeutic areas: Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS).

Sponsors: Stanford University.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University School of Medicine Palo Alto, California, United States?

Stanford University School of Medicine Palo Alto, California, United States has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University School of Medicine Palo Alto, California, United States conducted?

Stanford University School of Medicine Palo Alto, California, United States has 1 clinical trials on record. Their work covers Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS).

Is Stanford University School of Medicine Palo Alto, California, United States accredited by Crixeo Health?

Stanford University School of Medicine Palo Alto, California, United States has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University School of Medicine Palo Alto, California, United States?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.